The Latest Breaking News from Vaccine

Moderna Inc's Covid-19 vaccine is effective in children and adolescents, with mostly mild to moderate side effects, the United States Food and Drug Administration staff said.

Moderna Inc.’s COVID-19 vaccine is effective in children and adolescents, with mostly mild to moderate side effects, the U.S. Food and Drug Administration staff said.

GSK plc (NYSE:GSK) intends to engage with regulators immediately after reporting positive headline results from a pre-specified efficacy interim analysis of the AReSVi 006 phase III trial, it anticipates regulatory submissions in the second half of 2022. AReSVi 006 is a phase III trial investigating GSK’s respiratory syncytial virus (RSV) vaccine candidate…

Turkey Covid rules for UK holidaymakers explained as the country scraps PCR test and Covid vaccine entry requirements for those planning holidays this summer

The Food and Drug Administration (FDA) could grant emergency use authorization of a COVID-19 vaccination for the youngest kids later this month. Pfizer asked the agency to review data and authorize its COVID-19 vaccine for children ages 6 months to 5 years.

Loren McMath did not want to pressure her workers to get the jab, so she overhauled her whole business model over vaccine mandates, but less than six months later, they're gone.

The One Nation senator has continued to push the baseless claim that Australia could be forced to adopt restrictive health measures by the World Health Organization.

Moderna Inc (NASDAQ: MRNA) shares are trading lower Thursday as vaccine stocks fall in sympathy with Novavax Inc (NASDAQ: NVAX) following reports the FDA's decision on the company's COVID-19 vacci

About 52 per cent of Australians aged 65 and over have received their fourth COVID-19 vaccine dose.